CEL and arthritic joint disease: We hypothesized that BSSL is involved in the inflammatory process not only in rodents, but also in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and envision humanized anti-BSSL antibodies to be as a novel therapy to combat arthritis.